Pancreatic Cancer Research

ResearcherHeidelberg UniversityActive in the last 2 years

Susanne Roth

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5136-4686; OpenAlex author ID A5011368057, A5050743910. Sources: OpenAlex.

Their work

Papers
19 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
87
Papers, trials and grants by year

2019: 2 papers · 2020: none · 2021: 3 papers · 2022: 1 paper · 2023: 5 papers · 2024: 3 papers · 2025: 4 papers · 2026: 1 paper

Papers 19

  1. Pancreatic cancer. Co-author DOI 10.1038/s41572-026-00699-6↗
  2. Polymorphisms within autophagy-related genes as susceptibility biomarkers for pancreatic cancer: A meta-analysis of three large European cohorts and functional… Co-author DOI 10.1002/ijc.35196↗
  3. ChatGPT vs. surgeons on pancreatic cancer queries: accuracy & empathy evaluated by patients and experts. Co-author DOI 10.1016/j.hpb.2024.11.012↗
  4. Disrupting AGR2/IGF1 paracrine and reciprocal signaling for pancreatic cancer therapy. Co-author DOI 10.1016/j.xcrm.2024.101927↗
  5. ALDH1A3 promotes aggressive basal-like pancreatic cancer through an AP-1/RUNX2 enhancer network. Co-author DOI 10.1038/s41388-025-03530-w↗
  6. Metavert synergises with standard cytotoxics in human PDAC organoids and is associated with transcriptomic signatures of therapeutic response. Co-author DOI 10.1016/j.tranon.2024.102109↗
  7. A systemic look at pancreatic cancer patients: Predicting metastasis by studying the liver. Co-author DOI 10.1038/s41392-024-01964-4↗
  8. Tumour plasticity and tumour microenvironment interactions as potential immunologic targets for pancreatic cancer treatment. Co-author DOI 10.21037/cco-24-72↗
  9. Spatially Resolved Multi-Omics Single-Cell Analyses Inform Mechanisms of Immune Dysfunction in Pancreatic Cancer. Last author DOI 10.1053/j.gastro.2023.05.036↗
  10. Neutrophil-derived complement factor P induces cytotoxicity in basal-like cells via caspase 3/7 activation in pancreatic cancer Co-author DOI 10.1101/2023.10.28.564512↗
  11. Plasma extracellular vesicle messenger RNA profiling identifies prognostic EV signature for non-invasive risk stratification for survival prediction of patient… Co-author DOI 10.1186/s13045-023-01404-w↗
  12. Exploring the Neandertal legacy of pancreatic ductal adenocarcinoma risk in Eurasians. Co-author DOI 10.1186/s40659-023-00457-y↗
  13. Corrigendum: Clinical impact of molecular subtyping of pancreatic cancer. Co-author DOI 10.3389/fcell.2023.1179559↗
  14. [Partial pancreatoduodenectomy for pancreatic cancer : Oncological significance of nodal metastases location]. Co-author DOI 10.1007/s00104-022-01671-2↗
  15. [Influence of molecular pathology on oncological surgery of pancreatic cancer]. Co-author DOI 10.1007/s00104-021-01485-8↗
  16. Clinical Impact of Molecular Subtyping of Pancreatic Cancer. Co-author DOI 10.3389/fcell.2021.743908↗
  17. Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk. Co-author DOI 10.3389/fgene.2021.693933↗
  18. Adenosine in pancreatic cancer: Emerging combination therapies. Co-author DOI 10.1016/j.ebiom.2019.09.030↗
  19. Protocol of a prospective, monocentric phase I/II feasibility study investigating the safety of multimodality treatment with a combination of intraoperative ch… Co-author DOI 10.1136/bmjopen-2018-028696↗

Closest collaborators

The 25 strongest of 87 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Christoph W. Michalski · 7 shared papers, 2019–2026 · strength 1.40
  2. Thilo Hackert · 8 shared papers, 2019–2024 · strength 1.25
  3. Christoph Springfeld · 5 shared papers, 2019–2024 · strength 0.74
  4. Christoph Kahlert · 4 shared papers, 2023–2025 · strength 0.70
  5. Peter J. Bailey · 4 shared papers, 2021–2024 · strength 0.65
  6. John P. Neoptolemos · 4 shared papers, 2021–2024 · strength 0.65
  7. Martin Loos · 3 shared papers, 2024–2025 · strength 0.55
  8. Markus Wolfgang Büchler · 4 shared papers, 2019–2023 · strength 0.49
  9. Jingyu An · 3 shared papers, 2021–2024 · strength 0.41
  10. Xu Zhou · 3 shared papers, 2021–2024 · strength 0.41
  11. Jörg D. Hoheisel · 1 shared paper, 2024 · strength 0.36
  12. Chao Fang · 2 shared papers, 2025 · strength 0.34
  13. Zipeng Lu · 2 shared papers, 2025 · strength 0.34
  14. Yifeng Sun · 2 shared papers, 2025 · strength 0.34
  15. Hongzhen Li · 2 shared papers, 2025 · strength 0.34
  16. Zhiheng Zhang · 2 shared papers, 2025 · strength 0.34
  17. Shuang Nie · 2 shared papers, 2025 · strength 0.34
  18. Jorg H. Kleeff · 2 shared papers, 2025 · strength 0.34
  19. Ingrid Herr · 2 shared papers, 2025 · strength 0.34
  20. Martin Schneider · 1 shared paper, 2022 · strength 0.33
  21. Kongyuan Wei · 2 shared papers, 2021–2023 · strength 0.26
  22. Malte Buchholz · 2 shared papers, 2021–2023 · strength 0.26
  23. Thomas Mathias Gress · 2 shared papers, 2021–2023 · strength 0.26
  24. Xu Zhou · 1 shared paper, 2024 · strength 0.24
  25. Vinod P. Balachandran · 1 shared paper, 2026 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.